Clinical Trial Update: A Study to Evaluate Rocatinlimab (AMG 451) in Healthy Chinese Participants [Phase 1]

View source ↗

Summary

Phase 1 study evaluating Rocatinlimab (AMG-451) in healthy Chinese participants has completed, with Atopic Dermatitis identified as the condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Rocatinlimab (rocatinlimab)

Snippet

Sponsor: Amgen | Conditions: Atopic Dermatitis | Phase 1 | Status: COMPLETED